Lytix Biopharma AS announces approval by Hungarian authorities and ethics committee to start Phase IIa clinical trial with Lytixar (LTX-109) in Gram positive skin infections
Lytix Biopharma AS announces regulatory approval by Norwegian and Swedish authorities to commence Phase I clinical trial of OncoporeTM (LTX-315) in cancer